Otonomy IncCompany Details

Get alertedif Otonomy Inc gets funded!
United States
San Diego
Detailed industries:biotechnology
Company description

Led by David A. Weber, Ph.D., president and CEO, Otonomy has developed proprietary technology to advance therapeutics for diseases and disorders of the ear. The company has two product candidates in clinical development: - OTO-104, a steroid that has completed a Phase 1b clinical trial in Meniere’s disease patients; - OTO-201, an antibiotic that has recently completed a Phase 1b clinical trial in pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery.


Funding history

Key people
Jay B. LichterPresident & CEO
Peter BisgaardBoard of Directors, Director
Paul CayerCFO, Executive_Officer
Cayce DentonBoard Member
Jeffrey HarrisCo-Founder
Carl Lebel, Ph.d.Executive_Officer
Jay LichterDirector and CEO
Niall O'donnellObserver
Court TurnerDirector, Executive_Officer
David A. WeberCEO
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!